Tops & Flops Stocks
| Security | Change (%) | 1w | 1m | 1y ▲ | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Glycomimetics Inc. | -10.550% | -10.165% | -24.938% | -89.974% | -93.274% | -91.412% | -94.875% |
| Cara Therapeutics Inc. | -1.820% | 4.401% | -3.123% | -87.075% | -53.482% | -97.436% | -98.488% |
| Aclaris Therapeutics Inc | 1.740% | -2.072% | -13.782% | -84.807% | 11.947% | -91.730% | - |
| Carisma Therapeutics Inc. | 1.720% | -11.504% | -0.353% | -83.795% | -63.923% | -93.672% | -94.993% |
| Brainstorm Cell | 0.360% | -7.119% | -6.656% | -81.300% | 24.115% | -90.394% | -91.593% |
| Aspira Womens Health Inc. | 0.590% | -5.000% | -28.750% | -78.889% | -78.889% | -98.087% | -87.475% |
| Seres Therapeutics Inc | 5.260% | -8.121% | -38.805% | -77.994% | -44.901% | -86.119% | - |
| Coherus Bioscien. | -1.710% | 1.253% | -12.316% | -73.923% | -58.783% | -90.719% | -93.799% |
| Eagle Pharmaceuticals Inc | 1.750% | 16.000% | 6.422% | -70.256% | -3.333% | -88.515% | -90.731% |
| Minerva Neurosciences Inc. | -1.570% | 5.932% | -14.384% | -66.171% | -57.155% | -80.045% | - |
| Kezar Life Sciences | -1.830% | -2.727% | -11.570% | -63.851% | -38.857% | -91.440% | - |
| Prothena Corp. plc | -1.520% | -1.546% | -10.748% | -61.647% | -45.115% | -67.627% | 137.267% |
| Forte Biosciences Inc. | 1.350% | 6.383% | -39.516% | -59.732% | -53.488% | -98.770% | - |
| SCYNEXIS Inc. | -0.610% | -12.011% | -32.553% | -59.263% | -32.416% | -75.353% | - |
| Editas Medicine Inc | 0.030% | -2.166% | -32.537% | -59.131% | -64.034% | -93.532% | -84.992% |
| Syros Pharmaceuticals Inc. | -2.080% | 2.721% | -73.966% | -57.821% | -77.121% | -96.599% | - |
| Pacira Pharmaceuticals | 3.790% | 10.484% | -23.464% | -56.918% | -54.027% | -72.267% | -58.397% |
| Kala Pharmaceuticals Inc. | 0.870% | 0.675% | -9.767% | -56.788% | -19.939% | -96.254% | - |
| Organovo Holdings Inc. | 0.550% | -0.912% | 3.626% | -52.201% | -47.076% | -91.408% | -88.887% |
| TherapeuticsMD Inc. | 0.600% | 7.051% | 3.727% | -51.453% | -20.476% | -95.015% | -98.668% |
| Karyopharm Therapeutics Inc. | -0.260% | -6.498% | -29.939% | -44.799% | -16.755% | -85.125% | -91.138% |
| Intellia Therapeutics Inc | -3.220% | -3.881% | -16.420% | -41.554% | -29.845% | -84.443% | 57.259% |
| Regenxbio Inc | 3.850% | 0.935% | -18.182% | -35.714% | -35.329% | -59.762% | -65.649% |
| Puma Biotechnology Inc. | 3.270% | -2.118% | -37.060% | -33.988% | -43.201% | -65.634% | -76.653% |
| Champions Oncology Inc | -4.290% | 2.551% | -11.454% | -31.864% | -16.598% | -51.566% | - |